Literature DB >> 8630551

A longitudinal evaluation of bronchial responsiveness to methacholine in children: role of baseline lung function, gender, and change in atopic status.

F Forastiere1, G M Corbo, V Dell'Orco, R Pistelli, N Agabiti, D Kriebel.   

Abstract

A longitudinal study was done to evaluate the determinants of bronchial responsiveness (BR) to methacholine in children and adolescents. A cohort of 892 7- to 11-yr-old schoolchildren was restudied after a 3.5-yr interval. The same protocol for methacholine challenge (up to 64.0 mg/ml) and skin prick testing was employed at both the baseline survey and follow-up. An overall decline in the level of BR was observed, the geometric mean slope (percent decline in FEV1 per mg/ml of methacholine) decreasing from 0.68 (95% CI=0.61 to 0.75) to 0.51 (95% CI=0.46 to 0.57) (p<0.001). At both surveys, the strongest determinants of slope were baseline pulmonary function level (FEF25-75) and degree of atopic status. After adjusting for log FEF25-75, no gender difference was found in the first survey, whereas girls had greater BR than boys at follow-up. Longitudinal changes in skin prick test reactivity were associated with the BR level. Subjects in whom an initially positive skin prick test became negative (5.3%) had an increased slope at baseline but a follow-up slope similar to that of never skin-reactors. Conversely, those whose skin prick test converted from negative to positive (13.0%) had a slope similar to that of never-reactors at baseline but became stronger responders to methacholine than never-reactors at follow-up. Finally, responsiveness was highest in the presence of persistently positive skin prick testing (13.5%). In conclusion, BR declines from childhood to adolescence, paralleling the increase in lung function during this period; the decline is less pronounced in females. Changes in atopic status are associated with modifications in the BR level.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8630551     DOI: 10.1164/ajrccm.153.3.8630551

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  7 in total

1.  Ozone differentially modulates airway responsiveness in atopic versus nonatopic guinea pigs.

Authors:  Richard B Schlesinger; Mitchell D Cohen; Terry Gordon; Christine Nadziejko; Judith T Zelikoff; Maureen Sisco; Jean F Regal; Margaret G Ménache
Journal:  Inhal Toxicol       Date:  2002-05       Impact factor: 2.724

Review 2.  Conserved steroid hormone homology converges on nuclear factor κB to modulate inflammation in asthma.

Authors:  Asha S Payne; Robert J Freishtat
Journal:  J Investig Med       Date:  2012-01       Impact factor: 2.895

3.  Effect of dampness at home in childhood on bronchial hyperreactivity in adolescence.

Authors:  T Nicolai; S Illi; E von Mutius
Journal:  Thorax       Date:  1998-12       Impact factor: 9.139

4.  Sex differences in the association between neck circumference and asthma.

Authors:  Lisa Maltz; Ethan L Matz; Heather Gordish-Dressman; Dinesh K Pillai; Stephen J Teach; Carlos A Camargo; Monica J Hubal; Simran Behniwal; Guy D Prosper; Nicole Certner; Raman Marwah; Douglas M Mansell; Fisayo Nwachukwu; Risa Lazaroff; Yodit Tsegaye; Robert J Freishtat
Journal:  Pediatr Pulmonol       Date:  2016-01-15

5.  Airway responsiveness in mild to moderate childhood asthma: sex influences on the natural history.

Authors:  Kelan G Tantisira; Ryan Colvin; James Tonascia; Robert C Strunk; Scott T Weiss; Anne L Fuhlbrigge
Journal:  Am J Respir Crit Care Med       Date:  2008-04-17       Impact factor: 21.405

6.  Association of food allergy and decreased lung function in children and young adults with asthma.

Authors:  Michael G Sherenian; Anne M Singh; Lester Arguelles; Lauren Balmert; Deanna Caruso; Xiaobin Wang; Jacqueline Pongracic; Rajesh Kumar
Journal:  Ann Allergy Asthma Immunol       Date:  2018-08-03       Impact factor: 6.347

7.  Relationship between atopy and bronchial hyperresponsiveness.

Authors:  Dong In Suh; Young Yull Koh
Journal:  Allergy Asthma Immunol Res       Date:  2013-02-27       Impact factor: 5.764

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.